Pure Global

Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients - Trial NCT05441696

Access comprehensive clinical trial information for NCT05441696 through Pure Global AI's free database. This phase not specified trial is sponsored by Nihon Kohden and is currently Enrolling by invitation. The study focuses on Congestive Heart Failure. Target enrollment is 65 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05441696
Enrolling by invitation
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT05441696
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients
Pilot Study for the Evaluation of ezCVP in Heart Failure Patients

Study Focus

Congestive Heart Failure

ezCVP measurement

Observational

device

Sponsor & Location

Nihon Kohden

Palo Alto,Stanford, United States of America

Timeline & Enrollment

N/A

Jun 01, 2022

May 30, 2024

65 participants

Primary Outcome

Evaluate the difference between non-invasive CVP measurement at admission and at discharge,Evaluate the difference between non-invasive CVP measurement in right and left arms

Summary

Track changes in non-invasive central venous pressure across hospital stay and relationship
 with readmission

ICD-10 Classifications

Congestive heart failure
Heart failure
Hypertensive heart disease with (congestive) heart failure
Hypertensive heart and renal disease with (congestive) heart failure
Heart failure, unspecified

Data Source

ClinicalTrials.gov

NCT05441696

Device Trial